Clinical Trial

Efficacy of Donepezil in Patients With Chronic Tinnitus

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 4, 2025 (before its estimated December 9, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.
Trial Details
NCT Number NCT07153991
Lead Sponsor University of Sao Paulo
Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions Tinnitus
Enrollment 70 participants
Start Date 2021-11-19
Primary Completion 2025-12-09 (estimated)
Study Completion 2025-12-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-04